A
Ashish S. Patel
Researcher at University of Texas Southwestern Medical Center
Publications - 72
Citations - 2786
Ashish S. Patel is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Ulcerative colitis & Inflammatory bowel disease. The author has an hindex of 22, co-authored 64 publications receiving 2026 citations. Previous affiliations of Ashish S. Patel include Cincinnati Children's Hospital Medical Center & University of Texas at Dallas.
Papers
More filters
Journal ArticleDOI
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan,Lee A. Denson,Thomas D. Walters,Mi-Ok Kim,Urko M. Marigorta,Melanie Schirmer,Melanie Schirmer,Kajari Mondal,Chunyan Liu,Anne M. Griffiths,Joshua D. Noe,Wallace Crandall,Scott B. Snapper,Shervin Rabizadeh,Joel R. Rosh,Jason Shapiro,Stephen L. Guthery,David R. Mack,Richard Kellermayer,Michael D. Kappelman,Steven J. Steiner,Dedrick E. Moulton,David Keljo,Stanley N. Cohen,Maria Oliva-Hemker,Melvin B. Heyman,Anthony R. Otley,Susan S. Baker,Jonathan Evans,Barbara S. Kirschner,Ashish S. Patel,David Ziring,Bruce C. Trapnell,Francisco A. Sylvester,Michael C. Stephens,Robert N. Baldassano,James Markowitz,Judy H. Cho,Ramnik J. Xavier,Ramnik J. Xavier,Ramnik J. Xavier,Curtis Huttenhower,Curtis Huttenhower,Bruce J. Aronow,Greg Gibson,Jeffrey S. Hyams,Marla Dubinsky +46 more
TL;DR: The findings support the usefulness of risk stratification of paediatric patients with Crohn's disease at diagnosis, and selection of anti-TNFα therapy.
Journal ArticleDOI
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Thomas D. Walters,Mi-Ok Kim,Lee A. Denson,Anne M. Griffiths,Marla Dubinsky,James Markowitz,Robert N. Baldassano,Wallace Crandall,Joel R. Rosh,Marian Pfefferkorn,Anthony Otley,Melvin B. Heyman,Neal Leleiko,Susan S. Baker,Stephen L. Guthery,Jonathan Evans,David Ziring,Richard Kellermayer,Michael C. Stephens,David R. Mack,Maria Oliva-Hemker,Ashish S. Patel,Barbara S. Kirschner,Dedrick E. Moulton,Stanley N. Cohen,Sandra C. Kim,Chunyan Liu,Jonah Essers,Subra Kugathasan,Jeffrey S. Hyams +29 more
TL;DR: In children newly diagnosed with comparably severe CD, early monotherapy with anti-TNFα produced better overall clinical and growth outcomes at 1 year than earlymonotherapy with an immunomodulator.
Journal ArticleDOI
ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network
Wallace Crandall,M Kappelman,Richard B. Colletti,Ian H. Leibowitz,John E. Grunow,Sabina Ali,Howard I. Baron,James Berman,Brendan M. Boyle,Stanley A. Cohen,Fernando del Rosario,Lee A. Denson,Lynn Duffy,Mark Integlia,Sandra C. Kim,David E. Milov,Ashish S. Patel,Bess T. Schoen,Dorota Walkiewicz,Peter A. Margolis +19 more
TL;DR: Improvements suggest that practice sites are learning how to apply quality improvement methods to improve the care of patients.
Journal ArticleDOI
Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.
Millie D. Long,Wallace Crandall,Ian H. Leibowitz,Lynn Duffy,Fernando del Rosario,Sandra C. Kim,Mark Integlia,James Berman,John E. Grunow,Richard B. Colletti,Bess T. Schoen,Ashish S. Patel,Howard I. Baron,Esther J. Israel,George Russell,Sabina Ali,Hans H Herfarth,Christopher Martin,Michael D. Kappelman +18 more
TL;DR: One in five children with CD and one in three with UC are overweight or obese, and rates of obesity in UC are comparable to the general population.
Journal ArticleDOI
Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
Yael Haberman,Yael Haberman,Rebekah Karns,Phillip J. Dexheimer,Melanie Schirmer,Judith Somekh,Judith Somekh,Ingrid Jurickova,Tzipi Braun,Elizabeth Novak,Laura Bauman,Laura Bauman,Margaret H. Collins,Angela Mo,Michael J. Rosen,Erin Bonkowski,Nathan Gotman,Alison Marquis,Mason Nistel,Paul A. Rufo,Susan S. Baker,Cary G. Sauer,James Markowitz,Marian D. Pfefferkorn,Joel R. Rosh,Brendan M. Boyle,David R. Mack,Robert N. Baldassano,Sapana Shah,Neal S. Leleiko,Melvin B. Heyman,Anne M. Grifiths,Ashish S. Patel,Joshua D. Noe,Bruce J. Aronow,Subra Kugathasan,Thomas D. Walters,Greg Gibson,Sonia Davis Thomas,Sonia Davis Thomas,Kevin P. Mollen,Shai S. Shen-Orr,Curtis Huttenhower,Ramnik J. Xavier,Jeffrey S. Hyams,Lee A. Denson +45 more
TL;DR: In this article, the authors used RNAseq to define pre-treatment rectal gene expression, and fecal microbiota profiles, in 206 pediatric ulcerative colitis patients receiving standardised therapy.